• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    USANA Launches Next-Generation Celavive Skincare: Advanced Formulas, Expert Ambassadors, Proven Results

    9/11/25 7:47:00 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $USNA alert in real time by email

    Breakthrough products and upgrades redefine cellular skincare for radiant, resilient skin

    SALT LAKE CITY, Sept. 11, 2025 /PRNewswire/ -- USANA (NYSE:USNA), a global leader in cellular nutrition, has unveiled the next evolution of its Celavive skincare brand. The launch includes potent new offerings, enhanced formulas, and the recruitment of two globally acclaimed beauty authorities as international spokespeople. This new era of Celavive combines advanced science with real-world expertise to help people everywhere achieve their most youthful, glowing skin. The updated Celavive range merges cutting-edge scientific research with practical knowledge, with the goal of assisting individuals worldwide in maintaining radiant, youthful-looking skin.

    USANA's new, powerful, and updated Celavive skincare line

    To learn more about USANA's Celavive skincare line, please visit here.

    "At USANA, we believe skincare should do more than just sit on the surface — it should work at the cellular level to help skin look and feel its best," said Brent Neidig, USANA's Chief Commercial Officer. "That's why we've poured our hearts into developing this next-generation of our Celavive line and upgrading our formulations to work at the cellular level. These new innovations give our Brand Partners and customers confidence in products that deliver visible results, backed by cutting-edge science and expert education. Celavive is more than skincare — it's empowerment, resilience, and beauty you can believe in."

    Next-Generation Products That Deliver Visible Results

    Celavive Vitalizing Serum

    Now formulated with more than four times the actives, including BioPeptide-CS, Olivol24™, CoQ10, and plant-based Bakuchiol. This daily powerhouse serum encourages collagen synthesis, smooths the look of wrinkles, supports the skin barrier, and restores radiance — all without irritation.

    Celavive Bi-Phase Makeup Remover

    A brand-new, lightweight, dual-action formula that cleanses and conditions in one step. Infused with cucumber fruit complex, it melts away makeup and impurities while cooling, soothing, and hydrating skin — with no greasy residue.

    Celavive Contouring Face & Neck Crème

    This new, powerful "lift and firm" cream made with Feminage™, a clinically studied ingredient that helps support elasticity and smoothness. Specifically designed for women 35+, this formulation supports firmer contours and a radiant, youthful appearance.

    Celavive Triple Action Eye Cream

    With nearly 10x more active ingredients than before, this advanced eye cream targets the look of fine lines, puffiness, and dark circles. Enhanced with brightening peptides, it visibly improves the most delicate areas of skin for a refreshed, revitalized look.

    Celavive Perfecting Toner

    Upgraded to balance pH, boost hydration, refine texture, and protect against dullness and uneven tone. With a blend of peptides, botanicals, and antioxidants, it helps skin feel calm, clear, and resilient after every use.

    USANA has also refreshed the look of Celavive staples like the Creamy Foam Cleanser, Conditioning Makeup Remover, and Protective Day Cream and Lotion SPF 30 with sleek new packaging and branding.

    Global Ambassadors Bring Expertise and Inspiration

    To elevate Celavive education and connection, USANA is proud to announce that it has partnered with Joy Tan and Violet Chan as the brand's new global ambassadors with the goal of enhancing education and engagement with the brand on a worldwide scale. With more than a decade of experience in beauty education, services training, and industry partnerships across Asia, Joy and Violet are some of the most trusted voices in skincare.

    Together, they will enable USANA Brand Partners to communicate the scientific basis of Celavive in terms of practical application and visible outcomes. This will foster trust, boost assurance, and motivate engagement in markets worldwide.

    About USANA

    USANA (NYSE:USNA) has been providing premium-quality nutrition and lifestyle products for more than 30 years. From its award-winning supplements manufactured in its FDA-registered facility to its cutting-edge Celavive skincare and healthy living products, USANA is committed to empowering people to live healthier, more vibrant lives.

    Discover the future of skincare at USANA.com or explore the science at AskTheScientists.com.

    Media Contact:

    (801) 954-7645

    media(at)USANAinc(dot)com

     

    USANA Celavive's new global ambassadors Joy Tan and Violet Chan

    USANA Celavive Vitalizing Serum

    USANA Celavive Bi-Phase Makeup Remover

    USANA Celavive Contouring Face & Neck Creme

    USANA Celavive Triple Action Eye Cream

    USANA Celavive Perfecting Toner

    USANA Logo (PRNewsfoto/USANA)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/usana-launches-next-generation-celavive-skincare-advanced-formulas-expert-ambassadors-proven-results-302553589.html

    SOURCE USANA

    Get the next $USNA alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $USNA

    DatePrice TargetRatingAnalyst
    6/23/2023Buy
    Sidoti
    7/7/2022$78.00 → $53.00Hold → Underperform
    Jefferies
    4/14/2022$86.00Neutral
    DA Davidson
    More analyst ratings

    $USNA
    SEC Filings

    View All

    SEC Form 10-Q filed by USANA Health Sciences Inc.

    10-Q - USANA HEALTH SCIENCES INC (0000896264) (Filer)

    8/5/25 4:50:15 PM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by USANA Health Sciences Inc.

    SCHEDULE 13G/A - USANA HEALTH SCIENCES INC (0000896264) (Subject)

    7/29/25 2:50:55 PM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    USANA Health Sciences Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - USANA HEALTH SCIENCES INC (0000896264) (Filer)

    7/22/25 4:06:41 PM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    $USNA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Wentz Myron W gifted 145,000 shares (SEC Form 4)

    4 - USANA HEALTH SCIENCES INC (0000896264) (Issuer)

    9/5/25 10:13:30 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    Director Fuller Gilbert A sold $30,789 worth of shares (1,058 units at $29.10), closing all direct ownership in the company (SEC Form 4)

    4 - USANA HEALTH SCIENCES INC (0000896264) (Issuer)

    8/8/25 2:22:21 PM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    CHIEF SALES OFFICER Mulham David Mulham sold $106,364 worth of shares (3,515 units at $30.26), decreasing direct ownership by 28% to 9,260 units (SEC Form 4)

    4 - USANA HEALTH SCIENCES INC (0000896264) (Issuer)

    7/31/25 11:03:26 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    $USNA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    USANA Launches Next-Generation Celavive Skincare: Advanced Formulas, Expert Ambassadors, Proven Results

    Breakthrough products and upgrades redefine cellular skincare for radiant, resilient skin SALT LAKE CITY, Sept. 11, 2025 /PRNewswire/ -- USANA (NYSE:USNA), a global leader in cellular nutrition, has unveiled the next evolution of its Celavive skincare brand. The launch includes potent new offerings, enhanced formulas, and the recruitment of two globally acclaimed beauty authorities as international spokespeople. This new era of Celavive combines advanced science with real-world expertise to help people everywhere achieve their most youthful, glowing skin. The updated Celavive range merges cutting-edge scientific research with practical knowledge, with the goal of assisting individuals worldw

    9/11/25 7:47:00 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    USANA Expands Its Nutritionals Line With Powerful New Products and Enhanced Formulas

    Innovative offerings designed to help people live more vibrant lives SALT LAKE CITY, Sept. 9, 2025 /PRNewswire/ -- USANA, a worldwide leader in the field of cellular nutrition, has announced a fresh set of advancements to its existing Nutritionals product line. This includes both enhanced versions of popular items and completely new offerings, all created to help individuals globally improve their health and wellness practices. To learn more about USANA's Nutritionals line, please visit here. "At USANA, we're driven by a passion for pushing the boundaries of nutritional scienc

    9/9/25 7:37:00 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    Kevin Guest Encourages Self-Improvement as Path to Harmony, Fulfillment

    USANA Health Sciences Executive Chairman Shares Insightsfor September's Self-Improvement Month SALT LAKE CITY, Sept. 2, 2025 /PRNewswire/ -- In celebration of September's Self-Improvement Month, Kevin Guest, Executive Chairman of USANA Health Sciences (NYSE:USNA), is inspiring individuals to take meaningful steps toward personal growth and self-betterment. With the U.S. self-improvement industry valued at $12 billion annually, this month is a reminder that the journey to becoming our best selves is both a personal and collective endeavor. "True success isn't just about achievi

    9/2/25 7:27:00 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    $USNA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Sidoti initiated coverage on USANA

    Sidoti initiated coverage of USANA with a rating of Buy

    6/23/23 9:12:38 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    USANA downgraded by Jefferies with a new price target

    Jefferies downgraded USANA from Hold to Underperform and set a new price target of $53.00 from $78.00 previously

    7/7/22 9:35:48 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    DA Davidson initiated coverage on USANA with a new price target

    DA Davidson initiated coverage of USANA with a rating of Neutral and set a new price target of $86.00

    4/14/22 7:45:27 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    $USNA
    Leadership Updates

    Live Leadership Updates

    View All

    USANA Exec. Chairman Kevin Guest Celebrates Guitar Month, Stress Awareness Month for Harmony

    SALT LAKE CITY, April 1, 2025 /PRNewswire/ -- USANA Health Sciences (NYSE:USNA) Executive Chairman Kevin Guest marks April's convergence of International Guitar Month and Stress Awareness Month, as a perfect pairing that celebrates the healing power of music for mental well-being. While music has long been heralded as a universal remedy, the guitar offers far more than just melodies. Studies, stories and specialists alike agree: playing the guitar is a proven method to reduce stress. A passionate, performing guitarist himself, Guest invites others to join the cause. "Music has

    4/1/25 7:47:00 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    USANA Appoints New Chief Scientific Officer

    Dr. Kathryn Armstrong brings 17 years of scientific expertise to the company SALT LAKE CITY, Jan. 22, 2025 /PRNewswire/ -- USANA Health Sciences, Inc., a global leader in cellular nutrition, is proud to announce that Dr. Kathryn Armstrong, Ph.D., will be assuming the role of chief scientific officer at the company. Kathryn has served as USANA's executive vice president of research and development since July of 2024.  Kathryn's predecessor, Dr. Rob Sinnott, announced his retirement at the end of 2024, but will continue to assist in the company's pursuit for scientific excellence as its senior scientific fellow.

    1/22/25 7:07:00 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    USANA Executive Chairman Kevin Guest Encourages Connections with July's "Social Wellness Month"

    SALT LAKE CITY, July 1, 2024 /PRNewswire/ -- Throughout July, Kevin Guest, executive chairman at USANA Health Sciences (NYSE:USNA), is emphasizing boosting social connections during "Social Wellness Month." Social wellness—the ability to form meaningful relationships and interact positively with others—not only enhances our emotional well-being but also significantly impacts our overall health. "Strong social connections reduce stress, improve mental health, and even extend life expectancy," said Guest. "In a world where digital interactions often replace face-to-face communic

    7/1/24 7:13:00 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    $USNA
    Financials

    Live finance-specific insights

    View All

    USANA Health Sciences Reports Second Quarter 2025 Results and Reiterates Full-Year Outlook

    USANA Health Sciences, Inc. (NYSE:USNA) today announced financial results for its fiscal second quarter ended June 28, 2025. Key Financial Results Second Quarter 2025 vs. Second Quarter 2024 Net sales of $236 million versus $213 million, representing 11% year-over-year growth. Net earnings of $9.7 million versus $10.4 million. Diluted EPS of $0.52 as compared with $0.54. Adjusted diluted EPS(1) of $0.74 as compared with $0.54. Adjusted EBITDA(2) of $30 million versus $27 million. Direct selling Active Customers of 418,000 versus 468,000. Hiya Active Monthly Subscribers of 200,400. Company reiterates fiscal year 2025 outlook. Q2 2025 Financial Performance C

    7/22/25 4:05:00 PM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    USANA Schedules Second Quarter 2025 Earnings Release and Conference Call

    USANA Health Sciences, Inc. (NYSE:USNA) today announced that second quarter 2025 results will be released after the close of market on Tuesday, July 22, 2025. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institutional investors the following morning, Wednesday, July 23, 2025 at 11:00 a.m. Eastern Time. The call will be broadcast over the Internet and can be accessed at http://ir.usana.com. About USANA USANA develops and manufactures

    7/2/25 4:05:00 PM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    USANA Health Sciences Reports First Quarter 2025 Results and Reiterates Full-Year Outlook

    USANA Health Sciences, Inc. (NYSE:USNA) today announced financial results for its fiscal first quarter ended March 29, 2025. Key Financial Results First Quarter 2025 vs. First Quarter 2024 Net sales of $250 million versus $228 million, representing year-over-year growth of 10% and 12% in constant currency. Net earnings of $9.4 million versus $16.5 million. Diluted EPS of $0.49 as compared with $0.86. Adjusted diluted EPS(1) of $0.73 as compared with $0.86. Adjusted EBITDA(2) of $30 million versus $33 million. Direct selling Active Customers of 459,000 versus 494,000. Hiya Active Monthly Subscribers of 224,000. Company reiterates fiscal year 2025 outlook. Q1 2025 Financia

    4/22/25 4:05:00 PM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    $USNA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by USANA Health Sciences Inc. (Amendment)

    SC 13G/A - USANA HEALTH SCIENCES INC (0000896264) (Subject)

    2/13/24 10:49:58 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by USANA Health Sciences Inc. (Amendment)

    SC 13G/A - USANA HEALTH SCIENCES INC (0000896264) (Subject)

    2/13/23 11:26:45 AM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by USANA Health Sciences Inc. (Amendment)

    SC 13G/A - USANA HEALTH SCIENCES INC (0000896264) (Subject)

    2/11/22 3:48:24 PM ET
    $USNA
    Medicinal Chemicals and Botanical Products
    Health Care